Abstract:To gain more insight into the molecular mechanism of muscle growth and fiber-type transformations, we analyzed the effects of β 2 -adrenergic agonist clenbuterol (CB) and/or cyclosporin A (CsA), a potent inhibitor of calcineurin (CaN), on the muscle mass as well as on the mRNA levels of myosin heavy chains (MHC I, IIa, IId/x, IIb), using a real-time RT-PCR with specific primers in rat masseter. In comparison with control, the CB treatment significantly decreased the MHC I mRNA level (p < 0.01), but increased the MHC IId/x mRNA level (p < 0.01), and the CsA treatment significantly decreased the MHC I mRNA level (p < 0.05) in association with the significant decrease in MHC IIb mRNA level (p < 0.05). The CB+CsA treatment significantly decreased the levels of MHC I (p < 0.01) and IIa mRNAs (p < 0.05), but increased the MHC IId/x mRNA level (p < 0.001) in association with a significant decrease in MHC IIb mRNA level (p < 0.01), in comparison with control. The masseter muscle mass was significantly (p < 0.001) increased by either the CB or the CB + CsA treatment, but decreased with the CsA treatment (p < 0.01). These results suggest that in rat masseter muscle, CB has an anabolic action accompanying MHC mRNA I → IIa → IId/x sequence transition independently of CaN-signaling pathways, and CaN is involved in the type I fiber gene expression and the muscle mass maintenance of type IIb fiber.Key words: myosin heavy chain mRNA, muscle mass, clenbuterol, cyclosporin A, real time RT-PCR.Masticatory muscles have been known to be capable of adapting their mass and muscle phenotypes to meet a wide range of functional demands [1][2][3][4][5][6][7][8][9], as in limb muscles [10][11][12][13][14][15][16]. However, most of the studies on masticatory muscles to date have focused on describing the results rather than analyzing the molecular mechanism of muscle mass alteration and fibertype conversion. We have been particularly interested in the way mechanical signals influence the expression of subsets of genes, which determine muscle mass and phenotype. Pharmacological approaches have been used to dissect the signaling pathways that mediate the effect of mechanical load on muscle mass and phenotypes [9,[16][17][18]. A signaling mechanism involving calcineurin (CaN) has recently been suggested to promote the muscle growth as well as fibertype transformations [19][20][21][22][23][24][25][26]. The in vivo administration of cyclosporin A (CsA), a potent inhibitor of CaN, has been shown to prevent the fast-to-slow myosin heavy chain (MHC) isoform transition induced by the functional overload [18]. We found that in rat masseter muscle, the bite-opening treatment (i.e., a mechanical overload) produced not only the up-regulation of MHC IIa mRNA at the expense of MHC IIb mRNA independently of CaN-signaling pathways, but also the MHC mRNA transition from IIa to I and the muscle mass maintenance of type IIb fiber through CaN-signaling pathways [9]. However, the role of CaN in muscle growth and fiber-type transformations has long been ...